Quest Diagnostics, headquartered in Secaucus, New Jersey, employs 40,000 staff and provides diagnostic testing services to physicians, hospitals, and patients through a nationwide network. The company utilizes AI and digital solutions to enhance laboratory functions and support biopharmaceutical companies.
J. E Davis sold 39,191 shares of DGX on 2 April at $169.63 per share, worth a total of $6.6M. They now own 164,448 DGX shares, or a 23% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
